Claritas Rx, data integration and analytics company focused on specialty biopharmaceutical distribution channels, announced that it has partnered with Turning Point, an innovative specialty pharmacy network comprised of the largest independent, top-performing specialty pharmacies, to provide biopharmaceutical manufacturers in-depth analytics and insight based on data from the Turning Point specialty pharmacy network.
“Claritas is the perfect partner due to the cultural fit and expertise,” said Erik Halstrom, Managing Director of Turning Point. “The partnership combines Turning Point data with Claritas’ analytics providing manufacturers longitudinal insight into how patients experience treatment milestones across a therapeutic category. Providing manufacturers with faster, more actionable competitive insight and better forecasting, with visibility before and after treatment initiation, is so important as manufacturers look at market dynamics in their therapeutic categories.”
Recommended AI News: John Nichols joins MiX Telematics as Executive VP of Sales for North America
“We are excited to be able to partner with Turning Point and enhance visibility into the patient journey in collaboration with specialty pharmacy leaders,” said Stuart Kamin, VP of Corporate Strategy and Business Development at Claritas Rx. “Specialty pharmacies, as healthcare providers and distributors, are uniquely positioned to generate insights into barriers preventing a successful start on therapy and about how to best support patients over time. Insight from the broad reach and clinical expertise of the Turning Point specialty pharmacy network can help manufacturers optimize patient access.”
Recommended AI News: Comscore Launches New Brand Suitability Protections for Advertisers
Claritas will use its specialized analytics platform and aggregated specialty data across the Turning Point network to provide robust patient journey insights beyond what is traditionally available to manufacturers. Armed with this valuable information, Turning Point and Claritas will help manufacturers uncover the real-world drivers impacting patient access, duration of therapy, and other metrics key to brand success.
Recommended AI News: Daily AI Roundup: The 5 Coolest Things On Earth Today
Comments are closed, but trackbacks and pingbacks are open.